DESCRIPTION OF LICENSED PRODUCTS Sample Clauses

DESCRIPTION OF LICENSED PRODUCTS. Definitions used in this Section 1.0: INCREMENTAL RELEASE shall mean additional functionality that will be provided before FCS. There will be a series of small components of functionality delivered prior to the code freeze date. SUBSEQUENT RELEASE shall mean substantial release of new features to be delivered after FCS.
Sample 1
AutoNDA by SimpleDocs
DESCRIPTION OF LICENSED PRODUCTS. Leather, canvas webbing, and leather blend men’s and boys’ non-western belts and small personal leather and nonleather accessories, namely, wallets, key fobs, key chains, and Xxxx kits.
Sample 1
DESCRIPTION OF LICENSED PRODUCTS. Peritus Year 2000 Software, consisting of the following components: . Peritus COBOL Front-End . Peritus AutoEnhancer/2000 . Peritus Year 2000 Mass Change Processes and Methodologies for the software known as AutoEnhancer/2000 Type of License: Enterprise ---------------- Installation Site: Scheduled Delivery Date: ------------------ ------------------------ RS/6000 running AIX with PC October 21, 1996 workstations running Windows 95, located at Licensor's site in Boston, MA. Deliver To: Invoice To: ----------- ----------- N/A Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 000 Xxxxxxxxxx Xxxxxx Xxx Xxxx, XX 00000 Attn: Xxxxx Leuchinger License Fee: *******, to be credited against the perpetual License Fee set forth ------------ in Section 2 hereof in the event Customer exercises the License Conversion Option described therein. Annual Maintenance Fee: *** ----------------------- Specifications: See Attachment 1 attached hereto and made a part hereof --------------- Confidential material omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omissions. Special Terms and Conditions ----------------------------
Sample 1
DESCRIPTION OF LICENSED PRODUCTS. Peritus Year 2000 Software, consisting of the following components: . Peritus COBOL Front-End . Peritus AutoEnhancer/2000 . Peritus Year 2000 Mass Change Processes and Methodologies for the software known as AutoEnhancer/2000 Type of License: Scheduled Delivery Date: ---------------- ------------------------ Enterprise See Section 2 below
Sample 1
DESCRIPTION OF LICENSED PRODUCTS. A multicompartment bag array for use with the collection and/or storage of cryopreserved placental/umbilical cord blood. (See attached figures)
Sample 1
DESCRIPTION OF LICENSED PRODUCTS. Methods 2. Unit price (sale, lease, and/or use) 3. Units sold 4. Units leased 5. Gross sales 6. Net Sales to the Government Provide information A-C for each type of product or process sold
Sample 1
DESCRIPTION OF LICENSED PRODUCTS. We may from time to time and in our sole and absolute discretion, offer you, as part of the Services, the use of certain Software (as defined herein), Equipment (as defined herein), Telecommunications (as defined herein) or Media (as defined herein) (together the “Licensed Products”) for your use in connection with electronic trading, market data, information or other services, equipment or products made available to you by us or by any third party (together the “Auxiliary Services”). The Licensed Products may include, but will not necessarily be limited to, the installation of Software onto your personal system and the use of Equipment and Telecommunications necessary to use the Auxiliary Services. All Licensed Products provided to you by us will be covered by the terms of this Schedule unless stated otherwise by us. For the avoidance of doubt, our provision of the Licensed Products, and our granting of licenses with respect to the Licensed Products, to you shall constitute Services for all purposes under the Agreement.
Sample 1
AutoNDA by SimpleDocs

Related to DESCRIPTION OF LICENSED PRODUCTS

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Sublicense to Use the Xxxxxxx Trademarks As exclusive licensee of the rights to use and sublicense the use of the "Xxxxxxx," "Xxxxxxx Xxxxxx Investments, Inc." and "Xxxxxxx, Xxxxxxx & Xxxxx, Inc." trademarks (together, the "Xxxxxxx Marks"), you hereby grant the Trust a nonexclusive right and sublicense to use (i) the "Xxxxxxx" name and xxxx as part of the Trust's name (the "Fund Name"), and (ii) the Xxxxxxx Marks in connection with the Trust's investment products and services, in each case only for so long as this Agreement, any other investment management agreement between you and the Trust, or any extension, renewal or amendment hereof or thereof remains in effect, and only for so long as you are a licensee of the Xxxxxxx Marks, provided however, that you agree to use your best efforts to maintain your license to use and sublicense the Xxxxxxx Marks. The Trust agrees that it shall have no right to sublicense or assign rights to use the Xxxxxxx Marks, shall acquire no interest in the Xxxxxxx Marks other than the rights granted herein, that all of the Trust's uses of the Xxxxxxx Marks shall inure to the benefit of Xxxxxxx Trust Company as owner and licensor of the Xxxxxxx Marks (the "Trademark Owner"), and that the Trust shall not challenge the validity of the Xxxxxxx Marks or the Trademark Owner's ownership thereof. The Trust further agrees that all services and products it offers in connection with the Xxxxxxx Marks shall meet commercially reasonable standards of quality, as may be determined by you or the Trademark Owner from time to time, provided that you acknowledge that the services and products the Trust rendered during the one-year period preceding the date of this Agreement are acceptable. At your reasonable request, the Trust shall cooperate with you and the Trademark Owner and shall execute and deliver any and all documents necessary to maintain and protect (including but not limited to in connection with any trademark infringement action) the Xxxxxxx Marks and/or enter the Trust as a registered user thereof. At such time as this Agreement or any other investment management agreement shall no longer be in effect between you (or your successor) and the Trust, or you no longer are a licensee of the Xxxxxxx Marks, the Trust shall (to the extent that, and as soon as, it lawfully can) cease to use the Fund Name or any other name indicating that it is advised by, managed by or otherwise connected with you (or any organization which shall have succeeded to your business as investment manager) or the Trademark Owner. In no event shall the Trust use the Xxxxxxx Marks or any other name or xxxx confusingly similar thereto (including, but not limited to, any name or xxxx that includes the name "Xxxxxxx") if this Agreement or any other investment advisory agreement between you (or your successor) and the Fund is terminated.

  • License; Use Upon delivery to an Authorized Person or a person reasonably believed by Custodian to be an Authorized Person of the Fund of software enabling the Fund to obtain access to the System (the “Software”), Custodian grants to the Fund a personal, nontransferable and nonexclusive license to use the Software solely for the purpose of transmitting Written Instructions, receiving reports, making inquiries or otherwise communicating with Custodian in connection with the Account(s). The Fund shall use the Software solely for its own internal and proper business purposes and not in the operation of a service bureau. Except as set forth herein, no license or right of any kind is granted to the Fund with respect to the Software. The Fund acknowledges that Custodian and its suppliers retain and have title and exclusive proprietary rights to the Software, including any trade secrets or other ideas, concepts, know-how, methodologies, or information incorporated therein and the exclusive rights to any copyrights, trademarks and patents (including registrations and applications for registration of either), or other statutory or legal protections available in respect thereof. The Fund further acknowledges that all or a part of the Software may be copyrighted or trademarked (or a registration or claim made therefor) by Custodian or its suppliers. The Fund shall not take any action with respect tot the Software inconsistent with the foregoing acknowledgement, nor shall the Fund attempt to decompile, reverse engineer or modify the Software. The Fund may not xxx, sell, lease or provide, directly or indirectly, any of the Software of any portion thereof to any other person or entity without Custodian’s prior written consent. The Fund may not remove any statutory copyright notice or other notice included in the Software or on any media containing the Software. The Fund shall reproduce any such notice on any reproduction of the Software and shall add any statutory copyright notice or other notice to the Software or media upon Custodian’s request.

  • Product The term “

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!